Proposed tariffs on pharmaceutical imports could destabilize U.S. generic drug supply, warns Dr. Scott Gottlieb.

From antibiotics and blood-pressure medications to essential cancer treatments, almost all generic drugs consumed in the U.S. are manufactured overseas - primarily in China and India. This dependency ...

Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new ...

Benchmark S&P 500 falls more than 1.5 percent after Trump says import taxes on China will rise to 104 percent.

China vows to hit back at Trump’s tariffs which total 54pc; pharmaceuticals, semiconductors and gold have been excluded but ...

CSL Ltd (ASX:CSL) has seen shares fall nearly half a percent in afternoon trades on Thursday as the company responds to Trump ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

Across the ideological spectrum, people say U.S. manufacturing is in decline. They argue mostly about who’s to blame and how many tariffs we need to fix the problem. This widely told tale is wrong.

US President Donald Trump has again singled out Ireland's pharmaceutical industry as ... how Ireland has become a major offshore manufacturing centre for US pharma companies.